News

On the morning of July 11, 2025, in Hanoi, the General Office for Population – Ministry of Health, in collaboration with the United Nations Population Fund (UNFPA) in Vietnam, held a grand rally in response to World Population Day with the theme: "Reproductive Autonomy in a Changing World." The event attracted participation from central and local government agencies, healthcare organizations, international organizations, and notably, the presence of GENTIS – Genetic Testing Services JSC, a pioneering company in the field of genetic testing in Vietnam.

On July 5, 2025, at The Best of Vietnam 2025 awards ceremony, Genetic Analysis Services Joint Stock Company (GENTIS) was honored to receive the prestigious award recognizing it as one of the Top 10 Genetic Laboratories in Vietnam. This recognition is a well-deserved testament to GENTIS’s persistent efforts, innovation, and pioneering spirit in advancing the field of genetics in Vietnam.

From a startup in France, Eurofins has grown into one of the world’s leading scientific groups, particularly in the field of biological testing, including medical testing, with over 900 laboratories worldwide. The integration of GENTIS into the Eurofins network marks a strategic turning point, ushering in a new era for genetic testing in Vietnam and Southeast Asia.

A scientific study conducted by GENTIS, in collaboration with experts from Genoma and several other institutions in Vietnam and around the world, has been selected for an oral presentation at the ESHRE 2025 conference.

Continuing its mission to support the medical community in advancing genomic medicine in Vietnam, GENTIS is honored to participate in the 2025 National Conference on Medical Genetics as an official sponsor. This annual, nationwide scientific event brings together leading experts, scientists, physicians, and professionals in the field of genetics.

n modern medicine, laboratory testing is no longer just a supplementary tool but a critical factor in diagnosing and treating patients. However, a common misconception is that the quality of laboratory tests mainly depends on advanced equipment, test kits, or highly skilled technicians — as many facilities currently promote.

Two guest experts at the talk show themed “CAP Standards and Experience in Building a Laboratory” were Prof. Dr. Tran Duc Phan - Chairman of the Vietnam Society of Medical Genetics and Dr. Pham Dinh Minh - Director of R&D at GENTIS. In modern medical testing, especially in the field of genetics, quality management plays a crucial role in ensuring the accuracy and reliability of results. The CAP (College of American Pathologists) standard is one of the strictest quality management systems today, requiring meticulous control from sample collection to analysis and result reporting. Applying CAP standards helps improve professional capacity, standardize testing procedures, minimize errors, and increase the internationalization of results, bringing tangible benefits to both clinical doctors and patients.

On June 12, 2025, GENTIS Genetic Testing Center officially became the unit in Vietnam to achieve CAP (College of American Pathologists) certification for two tests: PGT (Pre-implantation Genetic Testing) and NIPT (Non-Invasive Prenatal Testing). This marks an important milestone in GENTIS's 15-year journey of continuous efforts to improve the quality of genetic testing services, contributing to the physical and mental health protection of the Vietnamese people.